Dr. Montserrat Bosch Grau holds a PhD in Biochemistry and Molecular Biology and brings more than twenty years of experience across neuroscience research, preclinical drug development and science-industry partnerships.
She developed her research career at the CNRS, Institut Curie and Institut Pasteur in Paris, and later spent five years leading the preclinical department at biotechnology company Sensorion, where she oversaw gene therapy and small-molecule programmes through to the clinical stage. Before joining the BBRC, she served as Chief Business Officer at the Occitanie Biotherapy and Bioproduction Integrator (OBBI, Inserm), where she fostered partnerships with industrial, hospital and academic stakeholders.
@barcelonabeta.bsky.social